Avanos Medical officer granted 2,211 RSUs

Hurley John Joseph reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hurley John Joseph reported acquisition or exercise transactions in this Form 4 filing.

Avanos Medical, Inc. reported that Principal Accounting Officer John Joseph Hurley received an award of 2,211 time-based restricted share units under the company’s 2021 Long Term Incentive Plan. These units vest in three equal installments on March 13, 2027, March 13, 2028, and March 13, 2029, and each unit is economically equivalent to one share of common stock. Following this compensation grant, his reported direct holdings increased to 13,592 shares or share-equivalents.

Insider Trade Summary

Grant/Award: 2,211 shares

Grant/Award 1 txn

Insider Hurley John Joseph

Role Principal Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,211	$0.00	$0.00

Holdings After Transaction: Common Stock — 13,592 shares (Direct)

Footnotes (1)

1. F1. Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 13, 2027, 1/3 on March 13, 2028 and 1/3 on March 13, 2029. Each TRSU is the economic equivalent of one share of Common Stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Avanos Medical (AVNS) report for John Joseph Hurley?

Avanos Medical reported that Principal Accounting Officer John Joseph Hurley received 2,211 time-based restricted share units as compensation. These units are tied to common stock and increase his reported direct holdings to 13,592 shares or share-equivalents after the award.

How many restricted share units did the Avanos Medical (AVNS) officer receive?

John Joseph Hurley received 2,211 time-based restricted share units. The units were granted at no cash price under Avanos Medical’s 2021 Long Term Incentive Plan, as amended, and each unit is the economic equivalent of one share of common stock.

When do the new Avanos Medical (AVNS) restricted share units vest?

The 2,211 time-based restricted share units vest in three equal installments. One-third vests on March 13, 2027, another third on March 13, 2028, and the final third on March 13, 2029, subject to the award’s standard vesting conditions.

What is the nature of the Avanos Medical (AVNS) Form 4 transaction?

The Form 4 shows a grant or award acquisition, coded “A,” rather than an open-market trade. It reflects compensation in the form of time-based restricted share units, not a purchase or sale of Avanos Medical common stock in the market.

How many Avanos Medical (AVNS) shares does the officer hold after the award?

After receiving the 2,211 restricted share units, John Joseph Hurley’s reported direct holdings total 13,592 shares. This figure reflects his position following the award, combining previously held shares with the newly granted share-equivalent units.

What plan governs the Avanos Medical (AVNS) restricted share unit grant?

The award was granted under Avanos Medical’s 2021 Long Term Incentive Plan, as amended. This plan provides equity-based compensation, and each time-based restricted share unit in this grant is economically equivalent to one share of the company’s common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 05:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hurley John Joseph

(Last) (First) (Middle)

5405 WINDWARD PARKWAY

SUITE 100

(Street)

ALPHARETTA GA 30004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		2,211(1)	A	$0	13,592	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 13, 2027, 1/3 on March 13, 2028 and 1/3 on March 13, 2029. Each TRSU is the economic equivalent of one share of Common Stock.

Remarks:

	/s/ John S. Fischer, as attorney-in-fact for John Joseph Hurley	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.